Aminopeptidase N (APN, EC 3.4.11.2) is a type 2 transmembrane zinc-dependent metallopeptidase of the superfamily of gluzincins, 1, 2) which forms a noncovalently bound homodimer on the cellular membrane. It has a conserved pentapeptide consensus sequence HEXXH representing a zinc binding motif in its extracellular metalloprotease domain. It expresses in many cells and tissues, including myeloids, fibroblasts, brain cells, hepatocytes, osteoclasts, endometrial cells, epithelial cells of the liver, kidney, intestine, and in synaptic membranes of central nervous system. 3,4) Because of its broad expression, the function of APN strongly depends on its location. The expression of APN is up-regulated in many types of cancer cells, and APN plays a crucial role in tumor progression, such as cell-cell contact, proliferation, tumor invasion and metastasis, and angiogenesis.
Because of its broad expression, the function of APN strongly depends on its location. The expression of APN is up-regulated in many types of cancer cells, and APN plays a crucial role in tumor progression, such as cell-cell contact, proliferation, tumor invasion and metastasis, and angiogenesis. [5] [6] [7] Therefore, APN as a therapeutic target for treatment of cancer was presented.
In recent years, many natural/synthetic APN inhibitors have been reported and proved to be clinically efficacious for the treatment of tumor. Bestatin, [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]leucine, obtained from culture filtrates of Streptomyces olivoreticuli, 8) is a low-molecularmass dipeptide. And Bestatin is also a potent competitive inhibitor (K i ϭ1. 4-4.1ϫ10 Ϫ6 M) of APN with antitumor activity and immunomodulating activity. However, Bestatin has significant bone marrow and mucosal toxicity. 9, 10) One of Lisoserine derivatives 16l was synthesized by our group showed similar enzyme activity inhibition to that of Bestatin. We found that the enzyme activity inhibition of 16l was similar to Bestatin determined by microsomal aminopeptidase N from porcine kidney microsomes which was commonly used in activity screening of APN inhibitor, [11] [12] [13] and the inhibition constant, K i , was also similar. However, the enzyme activity inhibition and cell viability inhibition of 16l determined using human tumor cells were greatly lower than Bestatin. And there was significant difference in cell migration and invasion inhibition. Therefore, we proposed that the crystal structure of APN is different between homo sapien and porcine. Computer aided drug design verified that because of the difference in structure, the binding pattern of 16l in the active site of homo sapien and porcine APN are different. The activity screening of APN inhibitor using aminopeptidase N from porcine should be only preliminary determination. The real activity screening should be determined using homo sapien aminopeptidase N.
MATERIALS AND METHODS

Chemicals
The chemical structures of 16l and Bestatin are shown in Fig. 1 . Bestatin was obtained from Apeloa Kangyu Pharmaceutical Co., Ltd., Zhejiang, China.
Cell Culture Human promyelocytic leukemia cells HL-60, human ovarian clear cell adenocarcinoma cell line ES-2 and mouse melanoma cell line B16 were maintained in RPMI-1640 supplemented with 10% fetal calf serum (FCS). These cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 .
Membrane Isolation 5ϫ10 7 ES-2 cells were washed with phosphate buffered saline (PBS), and resuspended in 14) The intact cell was removed by centrifugation at 400 g, 4°C for 5 min, and the cell debris in supernatant was collected by centrifugation at 12000 g, 4°C for 20 min. Then the isolated cell membrane was suspended in 5 ml PBS for enzyme activity assay.
Enzyme Activity Assay Determination of the enzyme activity of APN was determined using methods described previously. 5) In brief, microsomal aminopeptidase N (4 mg/ ml final concentration) from porcine kidney microsomes (L6007, Sigma, U.S.A.) as the enzyme in 50 mM PBS, pH 7.2, 1ϫ10 5 tumor cells or isolated ES-2 cell membrane were resuspended in PBS in a 96-well microtiter plate. Then different concentrations of compound were added separetely. After incubation with 1.6 mM of L-leucine-p-nitroanilide (L9125, Sigma) for 1 h at 37°C, the enzyme activity was estimated by measuring the absorbance at 405 nm using a plate reader (Varioskan, Thermo, U.S.A.).
Kinetics of Aminopeptidase Inhibition The inhibition constant, K i , of APN inhibitors was determined using the methods described previously, [15] [16] [17] and the substrate was L9125, the enzyme was microsomal aminopeptidase N from porcine kidney microsomes. 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) Assays 1ϫ10
4 per well of HL-60 were seeded in 96-well plate and allowed to grow for 4 h and the compounds were added at various concentration. Two days after treatment, cells were incubated with 1% of 0.5 mg/ml MTT reagent for an additional 4 h. After that, the culture was removed and 100 ml dimethyl sulfoxide (DMSO) was added. Absorbance at 570 nm was measured using a plate reader (Varioskan, Thermo), and absorbance at 630 nm was used as a reference. The inhibition rate of compounds were calculated by (optical density (OD) controlϪOD tested)/OD controlϫ100%, where OD is the mean value of three replicate well.
Migration Assay ES-2 cells were treated with 320 mM 16l or Bestatin in six-well plate for 2 d. Then cells were wounded by 200 ml pipette tip and washed with warmed PBS. At 0 h and after 6 h of incubation at 37°C, 5% CO 2 , images were taken.
In Vitro Invasion Assay In vitro invasion assay was performed using invasion assays as described previously.
18) Matrigel (Cat. 356234, BD Biosciences, U.S.A.) was diluted 1 : 19 with serum-free RPMI-1640 and 50 ml was used to coat each invasion chamber (Transwell; Corning 8-mm pore size; Corning, NY, U.S.A.). 1ϫ10 5 ES-2 cells, treated with 320 mM different compounds for 2 d, were added to the upper chamber supplemented with 320 mM of the inhibitors, while the lower compartment filled with 10% FCS in RPMI-1640. After incubation for 24 h, the Matrigel on the upper side of the filter was removed. The cells on the bottom were fixed with methanol and stained with 1 mg/ml crystal violet dye. The picture of invaded cells was obtained under a microscope (IX81, Olympus, Japan).
Homology Modeling and Docking The three dimensional structure of homo sapien and porcine APN were constructed using the MODELLER program 19) in Accelrys Discovery Studio 2.5 (Accelrys Inc., U.S.A.). The sequence of homo sapien APN (Swiss-Prot entry: P15144.4) and porcine APN (GenBank entry: CAA82641.1) were derived from NCBI protein database (http://www.ncbi.nlm.nih.gov). The template (PDB entry: 1Z1W) was obtained from RCSB Protein Data Bank (http://www.pdb.org). The constructed models were analyzed by Phi/Psi method.
Bestatin and 16l were docked to the active site of these two APN models by employing the FlexX2 docking program in SYBYL 7.0 package. MMFF94 charges were assigned to both proteins and ligands. The active sites including residues within 12 Å of the zinc ions of both proteins were prepared for the docking study. 30 poses were generated for each ligand by docking to the protein. The H-bond and hydrophobic interaction were revealed by Ligplot program. 20) HPLC Analysis The degradation of compound was analyzed by HPLC (Agilent Technologies 1200 Series), using a reversed phase column (Agilent Eclipse XDB-C18). The gradients started with 95% water and reached 100% methanol in 20 min. The flow rate was 2 ml/min. The chromatograms were monitored at 260 nm (the compound 16l has maximum absorbance at 260 nm, data not shown), and absorbance at 360 nm was used as a reference.
Statistical Analysis For data of migration and invasion assay, the significance of difference between groups was performed by the Student's t-test.
RESULTS
Activity Determination of APN Inhibitor Using
Aminopeptidase N from Porcine Kidney APN inhibitor should inhibit the enzyme activity of aminopeptidase N. Activity of aminopeptidase N from porcine kidney microsomes was estimated by quantifying the enzymatic cleavage of the substrate L-leucine-p-nitroanilide. The enzyme activity assay indicated that 16l and Bestatin dose-dependently inhibited the enzyme activity of porcine APN (Fig. 2A) . And 16l suppression of APN activity was similar to that of Bestatin.
To gain more insight into the inhibition of aminopeptidase N by two compounds, kinetic study of inhibition was carried out. Dixon method was employed to determine the K i values for APN inhibitors (Fig. 3) . The K i value for 16l and Bestatin was 3.56Ϯ0.4 mM and 3.73Ϯ0.24 mM. There was no significant difference.
Activity Determination of APN Inhibitor Using Human Tumor Cells Activity of aminopeptidase N on the human and mouse tumor cell surface of ES-2, HL-60 and B16 or from isolated ES-2 cell membrane was also estimated. As shown in Figs. 2B, C, D and E, in the concentration range of 12.8-1600 mM, Bestatin inhibited the enzyme activity in a dose-dependant manner. However, 16l suppression of APN activity was greatly lower than that of Bestatin. Moreover, Bestatin and 16l inhibition of mouse APN activity was lower than that of homo sapien APN activity. When estimated using isolated ES-2 cell membrane, APN enzyme activity inhibition of 16l was also greatly lower than that of Bestatin. And MTT assay data also indicated that 16l couldn't equally inhibit the cell viability of HL-60 which is sensitive to APN inhibitor and express high level of aminopeptidase N (Fig.  4) .
APN also participates in the invasion of tumor cells. 21, 22) Therefore, the activity of inhibiting tumor cell migration and invasion of the compounds was estimated. As shown in Fig. 5 , although 16l inhibit the migration and invasion of ES-2 cells which express high level of aminopeptidase N, it couldn't get to the equal level to that of Bestatin. Homology Modeling and Docking Both homo sapien and porcine APN share 33% sequence identity with 1Z1W (Fig. 6) . The constructed homo sapien APN has a 2.8 Å main chain atoms root mean square derivation (RMSD) with the template and 776 residues overlapped with 1Z1W's by a structural alignment. As to the constructed porcine APN, the main chain atoms RMSD are 5.99 Å and the number of overlapped residues with the template is 775. The two constructed models have a main chain atoms RMSD of 7.82 Å, and have 880 residues overlapped. In the Phi/Psi analysis, 793 residues of the homo sapien APN lie in the core region, 60 in the allowed region and 28 in the disallowed region (Fig.  7A) . As to the porcine APN model, 825 residues lie in the core region, 54 in the allowed region and 27 in the disallowed (Fig. 7B ). Both models show better performance than the template (620 residues in the core region, 116 in the allowed region and 48 in the disallowed region).
The binding pattern of inhibitors in the active site of homo sapien and porcine APN were different. However, in the hydrophobic pocket of each protein, the binding mode of 16l has similarity with Bestatin (Fig. 8) . In the binding site of homo sapien APN, O13 of 16l interacts with the zinc ion, with a short distance of 1.59 Å (Figs. 8A, C) . H-Bond interaction could be found between 16l and His309, Glu332 and Ser336. Hydrophobic interactions between 16l and residue Glu276, Val306, His309, Glu332, Glu339, Phe393, Tyr398 made significant contributions to the binding. More residues are involved in the H-bond interactions in the binding site of porcine APN (Figs. 8B, D) . O12 and O13 of 16l which bind to the zinc ion formed multiple H-bonds with surround residues (Glu299, Glu333, and His336). H-Bond interactions could also be found between O25 of 16l and OH of Tyr363. Hydrophobic walls formed by surround amino acids (His332, Glu333, Glu355, Asp383, Phe416, and Tyr421) also stabilize the ligand in the active site of porcine APN.
DISCUSSION
APN plays a crucial role in tumor progression and metastasis. 23) In non small cell lung cancer, human pancreatic carcinoma and prostate cancer, the expression of APN/CD13 for patients is associated with a poor prognosis and APN expression is supposed to be involved in the cancer invasion and metastasis. [24] [25] [26] [27] However, APN is highly glycosylated with carbohydrate which contribute to at lest 20% of the mass of the protein. Therefore, the enzyme expressed in prokaryon expression system was not used in activity screening. Porcine aminopeptidase N was extracted from kidney microsomal 1664 Vol. 33, No. 10 (Cat. L6007, Sigma). And it was commonly used in activity screening of APN inhibitor. [11] [12] [13] In the current study, we got a novel compound 16l which markedly inhibited the enzyme activity of porcine APN (Fig. 2A) . The inhibition constant of 16l was also similar to Bestatin determined using porcine APN (Fig. 3 ). However, when tested using human and mouse tumor cells or isolated cell membrane, 16l couldn't effectively inhibit the enzyme activity, cell viability, cell migration and invasion (Figs. 2B-E, 4, 5) . Computer aided drug design verified that because of the difference in structure, the binding pattern of 16l in the active site of homo sapien and porcine APN were different. Moreover, Bestatin and 16l suppression of mouse APN activity was lower than that of homo sapien APN activity. The difference in structure between mouse and homo sapien APN may cause to the difference in activity of the compounds. The compound 16l could effectively inhibit the enzyme activity of porcine APN, but not homo sapien APN located on the surface of tumor cells.
For most APN inhibitors reported in literatures, so far there are four possible binding sites, including a zinc binding group (ZBG), two hydrophobic groups interacting with the S 1 and S 1 Ј subsites in APN, and one appropriate group interacting with the S 2 Ј subsite surrounded by several Arg residues. It should be emphasized that Zn 2ϩ are necessary for binding among other three sites, and at least two binding sites are necessary for a potent inhibitor. The binding sites of 16l is S 1 Ј and S 2 Ј, and Bestatin is S 1 and S 1 Ј. The binding pattern of the two compounds is different, and the structure of homo sapien and porcine APN is also different. Therefore, the difference in activity of 16l against these two proteins may be caused by different binding patterns locating in the active site of these two enzymes. Only one oxgen atom of 16l binding to zinc ion of homo sapien APN is regarded to be less firm than two oxygen atoms (O12 and O13) of 16l binding to the zinc ion of porcine APN in a bidentate mode. Moreover, H-bond network formed by O12, O13 of 16l and residue surround the zinc ion in the porcine APN also make significant contribution to the ligand-receptor interaction. Moreover, we also determined whether 16l was degraded by proteases in ES-2 cells during enzyme activity assay and other cell assays using HPLC. The data indicated that 16l was not markedly degraded (Fig. 9) . And 16l couldn't effectively inhibit the activity of APN from isolated ES-2 cell membrane also verified that 16l was not degraded. Therefore, we proposed that the difference in structure between homo sapien and porcine APN caused to the difference in activity determination.
In conclusion, the activity of a novel synthesized APN inhibitor have been tested using enzyme and cell model. Although, 16l could inhibit the enzyme activity of porcine APN, it couldn't effectively inhibit the enzyme activity of APN located on the surface of human tumor cells. However, 16l made contributions to the study of structure-activity relationship. Then the constructed 3D-quantitative structure-activity relationship (QSAR) model was becoming more and more robust and directs the synthesis of new compound. Therefore, the activity screening of APN inhibitor using aminopeptidase N from porcine should be only preliminary determination. In the activity determination of new compound, the structure of different species target enzyme should be taken into consideration.
